2021
DOI: 10.1007/s13770-021-00356-x
|View full text |Cite
|
Sign up to set email alerts
|

Research Models of the Nanoparticle-Mediated Drug Delivery across the Blood–Brain Barrier

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 80 publications
0
5
0
Order By: Relevance
“…AD treatment, however, presents many difficulties due to its negative charge and poor stability. Several different approaches for AD delivery to the dermis through the epidermis have been previously investigated [ [21] , [22] , [23] , [24] ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…AD treatment, however, presents many difficulties due to its negative charge and poor stability. Several different approaches for AD delivery to the dermis through the epidermis have been previously investigated [ [21] , [22] , [23] , [24] ].…”
Section: Discussionmentioning
confidence: 99%
“…Here, we presented a new approach to address some issues of anionic AD by comparing AD emulsions that were electrostatically optimized using anionic MC and cationic MC-[NH 2 ] x as electrostatic emulsifiers. We successfully prepared a cationic MC-[NH 2 ] x emulsifier with different cationic charge ratios via sequential modification reactions after living polymerization [ 23 ]. The zeta potentials of the mixtures of cationic MC-[NH 2 ] x electrolytes and anionic AD electrolytes were almost identical to our calculated estimations [ 28 , 29 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Emerging technologies, such as advanced nanoparticle formulations and biomimetic nanoparticles, are revolutionizing drug transport across the BBB 80 , 81 . Noninvasive modulation through focused ultrasound techniques 82 and cutting-edge imaging methods for real-time monitoring 83 and assessing novel delivery methods 84 further enhance BBB-on-a-chip capabilities.…”
Section: Addressing Challenges and Future Directionsmentioning
confidence: 99%
“…Finally, free-standing BBB models would be easy to assembly with other organ modules and study the molecular transport between them. For more information about in vitro BBB models, the readers may refer to the references ( 42 , 43 ).…”
Section: In Vitro Blood-brain Barrier Models For Gbamentioning
confidence: 99%